# Vicarious SurgicalVR (RBOT) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/RBOT
## Company Profile
- Ticker: RBOT
- Exchange: NYSE
- Sector: MedTech
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 0.0638 USD
- Market cap: Not available USD
- Last updated: 2026-08-12
## Business Overview
### Next-Generation Surgical Robotics
Vicarious Surgical is developing a robotic platform for minimally invasive surgery. Its system uses human-like robotic arms and immersive visualization to give surgeons the sensation of operating from within the patient through a small incision.
### System Design Goals
The platform is intended to improve procedural access and efficiency while reducing invasiveness and healthcare costs. Vicarious is integrating robotics, visualization and surgeon controls into a single system intended for abdominal surgical procedures.
## Why The Stock Is Moving

As of Aug 12, 2026, RBOT closed down 1.85% at $0.0638. No new same-company headline was identified in the current news window.

## Future Catalysts

- Vicarious Surgical’s catalysts are surgical-robotics development, capital discipline, and any update that clarifies the path to commercialization. The market will care about whether the platform can move from concept to adoption.

## Recent News
- 2026-05-13 13:00 EST — [Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting](https://biopharmsignal.com/news/RBOT/vicarious-surgical-demonstrates-sustained-system-performance-and-complex-hernia--7110f26f) — Source: Vicarious SurgicalVR
- 2026-04-30 12:30 EST — [Vicarious Surgical Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/RBOT/vicarious-surgical-reports-first-quarter-2026-financial-results-906caf78) — Source: Vicarious SurgicalVR
- 2026-03-30 20:15 EST — [Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair](https://biopharmsignal.com/news/RBOT/vicarious-surgical-completes-integrated-benchtop-testing-of-full-surgical-instru-72be302b) — Source: Vicarious SurgicalVR
- 2026-03-25 20:15 EST — [Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing](https://biopharmsignal.com/news/RBOT/vicarious-surgical-begins-quotation-on-the-otcqb-as-part-of-strategic-path-towar-43dfb064) — Source: Vicarious SurgicalVR